Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.110
+0.230 (5.93%)
At close: Sep 18, 2026, 4:00 PM EDT
3.918
-0.192 (-4.66%)
After-hours: Sep 18, 2026, 7:39 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.42 million as of September 18, 2026. Its market cap has increased by 13.03% in one year.
Market Cap
13.42M
Enterprise Value
3.98M
1-Year Change
13.03%
Ranking
Category
Stock Price
$4.11
ChartMarket Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.42M, a decrease of -79.67%. That is a compound annual growth rate of -39.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 13.42M | -45.54% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 13.76M |
| BioVie | 13.58M |
| GT Biopharma | 13.48M |
| Enlivex | 13.42M |
| CalciMedica | 13.31M |
| Moolec Science | 13.14M |
| Adial Pharmaceuticals | 12.95M |
| AEON Biopharma | 12.59M |